SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314 | -50.3% | 131,847 | 0.0% | 0.04% | -43.5% |
| Q2 2023 | $632 | -99.9% | 131,847 | 0.0% | 0.06% | -21.5% |
| Q1 2023 | $747,572 | +1.2% | 131,847 | 0.0% | 0.08% | -14.1% |
| Q4 2022 | $738,343 | -12.7% | 131,847 | 0.0% | 0.09% | -12.4% |
| Q3 2022 | $846,000 | +87.2% | 131,847 | 0.0% | 0.10% | +101.9% |
| Q2 2022 | $452,000 | -51.9% | 131,847 | 0.0% | 0.05% | -45.3% |
| Q1 2022 | $939,000 | -14.5% | 131,847 | 0.0% | 0.10% | -7.8% |
| Q4 2021 | $1,098,000 | +19.6% | 131,847 | 0.0% | 0.10% | +90.7% |
| Q3 2021 | $918,000 | -70.8% | 131,847 | 0.0% | 0.05% | -70.2% |
| Q2 2021 | $3,145,000 | +15.8% | 131,847 | 0.0% | 0.18% | +19.1% |
| Q1 2021 | $2,715,000 | -15.9% | 131,847 | 0.0% | 0.15% | -13.1% |
| Q4 2020 | $3,230,000 | – | 131,847 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |